Impact of the COVID-19 Pandemic on Youth Substance Use and Substance-Related Risk Factors and Outcomes : Implications for Prevention, Treatment, and Policy - 12/07/24

Doi : 10.1016/j.pcl.2024.05.002

Christopher J. Hammond, MD, PhD ^a,^b,^⁎ , Kathryn Van Eck, PhD ^b,^c, Hoover Adger, MD, MPH, MBA ^b
^a Division of Child & Adolescent Psychiatry, Department of Psychiatry, Johns Hopkins University School of Medicine, Johns Hopkins Bayview, 5500 Lombard Street, Baltimore, MD 21224, USA
^b Division of Adolescent & Young Adult Medicine, Department of Pediatrics, Johns Hopkins University School of Medicine, 200 North Wolfe Street, Baltimore, MD 21287, USA
^c Kennedy Krieger Institute, 1741 Ashland Avenue, Baltimore, MD 21205, USA

^∗Corresponding author. Johns Hopkins Bayview, 5500 Lombard Street, Baltimore, MD 21224.Johns Hopkins Bayview5500 Lombard StreetBaltimoreMD21224

conectar o crear una cuenta

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Resumen

Youth substance use and substance use disorders (SUD) are major public health issues associated with significant societal cost. The coronavirus SARS-CoV-2 (COVID-19) pandemic and pandemic-related lockdowns, school closures, and social distancing dramatically impacted the daily lives of young people worldwide, resulting in major disruptions to normal developmental trajectories and complex (and at times opposing effects) on different SUD risk and protective factors, which contributed to inconsistent outcomes. During the COVID-19 pandemic, substance use prevalence rates decreased in the general population of US youth, but increased for certain vulnerable subgroups. Additionally, overdose deaths related to fentanyl rose significantly among US youth.

El texto completo de este artículo está disponible en PDF.

Keywords : Youth substance use, Youth substance use disorders, COVID-19 pandemic, Risk factors, Vulnerable subgroups, Substance use treatment